Healthcare provider profile · identity verified

Emre H Noteroglu, M.D.

Internal Medicine · HARRISON, NY · NPI 1659305217

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1269	364
Amlodipine Besylate	Amlodipine Besylate	929	244
Rosuvastatin Calcium	Rosuvastatin Calcium	826	245
Levothyroxine Sodium	Levothyroxine Sodium	561	153
Losartan Potassium	Losartan Potassium	472	124
Metoprolol Succinate	Metoprolol Succinate	466	130
Eliquis	Apixaban	417	95
Escitalopram Oxalate	Escitalopram Oxalate	369	104
Simvastatin	Simvastatin	349	94
Lisinopril	Lisinopril	292	82
Furosemide	Furosemide	268	78
Gabapentin	Gabapentin	265	85
Pantoprazole Sodium	Pantoprazole Sodium	238	69
Hydrochlorothiazide	Hydrochlorothiazide	235	71
Tamsulosin Hcl	Tamsulosin Hcl	210	48
Doxycycline Hyclate	Doxycycline Hyclate	206	175
Metformin Hcl	Metformin Hcl	192	55
Ezetimibe	Ezetimibe	188	50
Omeprazole	Omeprazole	187	59
Synthroid	Levothyroxine Sodium	149	45
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	136	107
Atenolol	Atenolol	126	30
Clopidogrel	Clopidogrel Bisulfate	119	33
Mirtazapine	Mirtazapine	119	29
Finasteride	Finasteride	116	30
Azithromycin	Azithromycin	111	93
Zolpidem Tartrate	Zolpidem Tartrate	111	26
Famotidine	Famotidine	110	29
Quetiapine Fumarate	Quetiapine Fumarate	109	27
Eszopiclone	Eszopiclone	104	28
Allopurinol	Allopurinol	103	25
Metformin Hcl Er	Metformin Hcl	100	31
Potassium Chloride	Potassium Chloride	100	33
Sertraline Hcl	Sertraline Hcl	99	29
Olmesartan Medoxomil	Olmesartan Medoxomil	96	27
Alprazolam	Alprazolam	92	28
Clonazepam	Clonazepam	91	18
Fluoxetine Hcl	Fluoxetine Hcl	89	21
Pravastatin Sodium	Pravastatin Sodium	88	27
Trazodone Hcl	Trazodone Hcl	88	22
Valsartan	Valsartan	88	23
Duloxetine Hcl	Duloxetine Hcl	87	29
Metoprolol Tartrate	Metoprolol Tartrate	85	25
Montelukast Sodium	Montelukast Sodium	80	25
Buspirone Hcl	Buspirone Hcl	77	16
Paxlovid	Nirmatrelvir/Ritonavir	76	75
Donepezil Hcl	Donepezil Hcl	74	22
Pregabalin	Pregabalin	73	16
Lorazepam	Lorazepam	71	14
Triamcinolone Acetonide	Triamcinolone Acetonide	70	56
Bupropion Hcl	Bupropion Hcl	69	15
Jardiance	Empagliflozin	69	22
Ketoconazole	Ketoconazole	66	34
Ramipril	Ramipril	63	19
Albuterol Sulfate Hfa	Albuterol Sulfate	54	24
Citalopram Hbr	Citalopram Hydrobromide	53	13
Januvia	Sitagliptin Phosphate	53	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	53	18
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	51	14
Bupropion Xl	Bupropion Hcl	50	17
Colchicine	Colchicine	50	21
Meloxicam	Meloxicam	47	19
Memantine Hcl	Memantine Hcl	46	13
Methylprednisolone	Methylprednisolone	46	43
Xarelto	Rivaroxaban	46	15
Carvedilol	Carvedilol	45	15
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	45	35
Oxycodone Hcl	Oxycodone Hcl	45	14
Diazepam	Diazepam	42	11
Prednisone	Prednisone	42	21
Hydralazine Hcl	Hydralazine Hcl	41	suppressed
Tramadol Hcl	Tramadol Hcl	41	20
Enalapril Maleate	Enalapril Maleate	40	11
Warfarin Sodium	Warfarin Sodium	40	suppressed
Alendronate Sodium	Alendronate Sodium	39	suppressed
Myrbetriq	Mirabegron	39	suppressed
Benazepril Hcl	Benazepril Hcl	38	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	37	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	36	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	36	11
Mupirocin	Mupirocin	36	25
Venlafaxine Hcl Er	Venlafaxine Hcl	36	suppressed
Cefuroxime	Cefuroxime Axetil	33	26
Spironolactone	Spironolactone	33	suppressed
Valacyclovir	Valacyclovir Hcl	33	18
Klor-Con M20	Potassium Chloride	32	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	30	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	29	suppressed
Glipizide Er	Glipizide	28	suppressed
Linzess	Linaclotide	28	suppressed
Fluconazole	Fluconazole	27	16
Ipratropium Bromide	Ipratropium Bromide	27	suppressed
Nebivolol Hcl	Nebivolol Hcl	27	suppressed
Verapamil Er	Verapamil Hcl	27	suppressed
Celecoxib	Celecoxib	25	suppressed
Torsemide	Torsemide	25	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Sotalol	Sotalol Hcl	24	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Fosinopril Sodium	Fosinopril Sodium	23	suppressed
Glimepiride	Glimepiride	23	suppressed
Irbesartan	Irbesartan	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Memantine Hcl Er	Memantine Hcl	20	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	14
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Cefdinir	Cefdinir	18	17
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Dutasteride	Dutasteride	17	suppressed
Fluticasone Propionate	Fluticasone Propionate	17	11
Folic Acid	Folic Acid	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Ozempic	Semaglutide	17	suppressed
Labetalol Hcl	Labetalol Hcl	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	12
Mometasone Furoate	Mometasone Furoate	16	suppressed
Olanzapine	Olanzapine	16	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Digoxin	Digoxin	15	suppressed
Estradiol	Estradiol	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Cephalexin	Cephalexin	14	13
Hydrocortisone	Hydrocortisone	14	suppressed
Paxlovid (Eua)	Nirmatrelvir/Ritonavir	14	14
Propranolol Hcl	Propranolol Hcl	14	suppressed
Testosterone	Testosterone	14	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Epinephrine	Epinephrine	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Nystatin	Nystatin	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	12	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	12	12
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Lipitor	Atorvastatin Calcium	11	suppressed
Mirabegron Er	Mirabegron	11	suppressed
Nadolol	Nadolol	11	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error